Charles River Laboratories International Interest Expense 2011-2026 | CRL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Charles River Laboratories International

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
-22.6 M	-16.5 M	137 M	59.3 M	73.9 M	86.4 M	60.9 M	63.8 M	29.8 M	27.7 M	15.1 M	12 M	21 M	33.3 M	42.6 M	35.3 M	21.7 M	22.3 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
137 M	-22.6 M	39 M

Quarterly Interest Expense Charles River Laboratories International

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2
-124 M	-22.6 M	154 K	-12.2 M	-	2.59 M	-2.24 M	5.83 M	-	-6.26 M	-2.66 M	34.4 M	-	11.4 M	3.7 M	9.43 M	-	16.5 M	16.2 M	29.7 M	-	18.9 M	19.4 M	15.1 M	-	5.7 M	20.8 M	9.99 M	-	17.2 M	18.6 M	11.2 M	-	7.67 M	7.4 M	6.98 M	-	7.08 M	8.91 M	4.21 M	-	3.85 M	4.38 M	3.02 M	-	3 M	3.37 M	2.8 M	-	2.32 M	7.54 M	8.28 M	-	8.52 M	8.08 M	8.44 M	-	11.9 M	10.7 M	10 M	12.6 M	7.1 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
34.4 M	-124 M	5.31 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Quest Diagnostics Incorporated DGX	26 M	$ 202.18	-0.43 %	$ 22.4 B	USA
Celcuity CELC	5.33 M	$ 88.24	-0.35 %	$ 4.13 B	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Co-Diagnostics CODX	106 K	$ 3.78	-11.89 %	$ 5.03 M	USA
Fulgent Genetics FLGT	153 K	$ 18.35	-1.77 %	$ 565 M	USA
Castle Biosciences CSTL	144 K	$ 20.66	-0.19 %	$ 599 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-595 K	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	-10.5 M	$ 129.82	-1.37 %	$ 16.3 B	USA
Interpace Biosciences IDXG	-394 K	$ 1.58	-1.56 %	$ 6.99 M	USA
CareDx, Inc CDNA	524 K	$ 24.08	4.83 %	$ 1.28 B	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
Illumina ILMN	340 M	$ 166.89	3.68 %	$ 25.9 B	USA
ICON Public Limited Company ICLR	337 M	$ 147.72	1.05 %	$ 11.6 B	Irlanda
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Mettler-Toledo International MTD	68.5 M	$ 1 154.47	2.03 %	$ 23.8 B	Schweiz
Genetic Technologies Limited GENE	17.6 K	-	-	$ 7.1 B	Australia
National Research Corporation NRC	-95 K	$ 18.31	-2.55 %	$ 410 M	USA
Natera NTRA	4.07 M	$ 216.97	2.31 %	$ 29.7 B	USA
Lantheus Holdings LNTH	31.3 M	$ 104.67	0.14 %	$ 7.06 B	USA
Pacific Biosciences of California PACB	14.8 M	$ 1.32	0.76 %	$ 396 M	USA
Medpace Holdings MEDP	-5.34 M	$ 467.5	0.03 %	$ 13.5 B	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
NeoGenomics NEO	296 K	$ 11.09	-0.54 %	$ 1.42 B	USA
Myriad Genetics MYGN	800 K	$ 4.32	-0.23 %	$ 400 M	USA
Personalis PSNL	205 K	$ 9.79	2.09 %	$ 874 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 26.69	0.87 %	$ 25.3 B	Niderland
Senseonics Holdings SENS	-23 K	$ 7.24	0.84 %	$ 302 M	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	2.58 M	-	-	$ 2.69 B	USA
Biomerica BMRA	367	$ 2.0	-2.44 %	$ 4.59 M	USA
Twist Bioscience Corporation TWST	-903 K	$ 80.79	6.07 %	$ 4.83 B	USA
Laboratory Corporation of America Holdings LH	224 M	$ 265.03	-0.42 %	$ 22.1 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 473.72	1.03 %	$ 179 B	USA
Trinity Biotech plc TRIB	6.75 M	$ 0.68	4.18 %	$ 244 M	Irlanda
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	38.1 M	$ 9.3	2.2 %	$ 2.02 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA